VS

Venkatesan Sreenivasan Balasubramanian

Director Director DIN 02547465
DIN 02547465 First appointment Mar 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Mar 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkatesan Sreenivasan Balasubramanian

Data last updated:

Venkatesan Sreenivasan Balasubramanian was a Director at Zeez Pharmaceuticals Private Limited (2009–2014). The company operates in Pharma.

DIN 02547465
Primary Designation Director
Industry Pharma
First Appointment 17 Mar 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeez Pharmaceuticals Private Limited U51909TN2009PTC071001
Director17 Mar 20092009₹1.94 Cr (FY 2015)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zeez Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Venkatesan Sreenivasan Balasubramanian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatesan Sreenivasan Balasubramanian

Venkatesan Sreenivasan Balasubramanian was first appointed on 17 Mar 2009 as Director at Zeez Pharmaceuticals Private Limited.

Venkatesan Sreenivasan Balasubramanian held 1 earlier board appointment: Zeez Pharmaceuticals Private Limited (Director, 17 Mar 2009 to 13 Oct 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available